Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells
2003

Resistance to Apoptosis in Pancreatic Cancer Cells

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Trauzold A, Schmiedel S, Röder C, Tams C, Christgen M, Oestern S, Arlt A, Westphal S, Kapischke M, Ungefroren H, Kalthoff H

Primary Institution: Molecular Oncology, Clinic for General Surgery, UK S-H, Campus Kiel, Germany

Hypothesis

What are the mechanisms behind the resistance to apoptosis in pancreatic adenocarcinoma cells?

Conclusion

Pancreatic adenocarcinoma cells exhibit multiple changes in apoptosis-related protein expression that contribute to their resistance to apoptosis.

Supporting Evidence

  • Pancreatic adenocarcinoma cells show resistance to CD95 and TRAIL-mediated apoptosis despite expressing death receptors.
  • Resistance is associated with downregulation of pro-apoptotic proteins and upregulation of anti-apoptotic proteins.
  • Expression levels of apoptosis-related proteins differ significantly between sensitive and resistant pancreatic cancer cell lines.

Takeaway

Some cancer cells are like superheroes that can avoid getting hurt by treatments that usually make other cells die. This study looked at why pancreatic cancer cells are so good at avoiding death.

Methodology

The study analyzed the expression levels of apoptosis-related proteins in five pancreatic cancer cell lines and assessed their sensitivity to apoptosis-inducing agents.

Limitations

The study focused only on a limited number of pancreatic cancer cell lines and may not represent all pancreatic cancers.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601330

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication